CA2708038A1 - Slope-based compensation - Google Patents
Slope-based compensation Download PDFInfo
- Publication number
- CA2708038A1 CA2708038A1 CA2708038A CA2708038A CA2708038A1 CA 2708038 A1 CA2708038 A1 CA 2708038A1 CA 2708038 A CA2708038 A CA 2708038A CA 2708038 A CA2708038 A CA 2708038A CA 2708038 A1 CA2708038 A1 CA 2708038A1
- Authority
- CA
- Canada
- Prior art keywords
- sample
- slope
- analyte concentration
- output signal
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012491 analyte Substances 0.000 claims abstract description 222
- 238000000034 method Methods 0.000 claims description 101
- 238000004458 analytical method Methods 0.000 claims description 55
- 230000004044 response Effects 0.000 claims description 39
- 238000005534 hematocrit Methods 0.000 claims description 34
- 239000013060 biological fluid Substances 0.000 claims description 28
- 238000005259 measurement Methods 0.000 claims description 28
- 238000004082 amperometric method Methods 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 230000005284 excitation Effects 0.000 claims description 9
- 238000004891 communication Methods 0.000 claims description 6
- 238000010606 normalization Methods 0.000 claims description 5
- 230000004075 alteration Effects 0.000 claims description 2
- 238000006479 redox reaction Methods 0.000 abstract description 12
- 239000000523 sample Substances 0.000 description 126
- 230000003287 optical effect Effects 0.000 description 30
- 241001274197 Scatophagus argus Species 0.000 description 14
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 13
- 101100364971 Mus musculus Scai gene Proteins 0.000 description 13
- 239000004020 conductor Substances 0.000 description 13
- 241000894007 species Species 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000012472 biological sample Substances 0.000 description 9
- 238000012937 correction Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000004832 voltammetry Methods 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 235000012601 Euterpe oleracea Nutrition 0.000 description 2
- 244000207620 Euterpe oleracea Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000003650 acai Nutrition 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000002277 temperature effect Effects 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000081 effect on glucose Effects 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1271607P | 2007-12-10 | 2007-12-10 | |
| US61/012,716 | 2007-12-10 | ||
| PCT/US2008/085768 WO2009108239A2 (en) | 2007-12-10 | 2008-12-06 | Slope-based compensation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2708038A1 true CA2708038A1 (en) | 2009-09-03 |
Family
ID=40845259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2708038A Abandoned CA2708038A1 (en) | 2007-12-10 | 2008-12-06 | Slope-based compensation |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10739350B2 (enExample) |
| EP (2) | EP3438661B1 (enExample) |
| JP (3) | JP5812603B2 (enExample) |
| CN (2) | CN103760356B (enExample) |
| BR (1) | BRPI0820670A2 (enExample) |
| CA (1) | CA2708038A1 (enExample) |
| MX (1) | MX2010006392A (enExample) |
| RU (2) | RU2546012C2 (enExample) |
| TW (2) | TWI534429B (enExample) |
| WO (1) | WO2009108239A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2700861T3 (es) | 2008-07-10 | 2019-02-19 | Ascensia Diabetes Care Holdings Ag | Sistemas y métodos que incluyen ciclos de trabajo amperométricos y voltamétricos |
| CN102227505B (zh) | 2008-12-08 | 2016-05-11 | 拜尔健康护理有限责任公司 | 用于生物传感器的低总盐试剂组合物和系统 |
| RU2509304C2 (ru) | 2008-12-08 | 2014-03-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Биосенсорная система с корректировкой сигнала |
| CN102471796A (zh) | 2009-07-27 | 2012-05-23 | 舒尔传感器有限公司 | 传感器设备的改进 |
| TWI391675B (zh) * | 2009-11-13 | 2013-04-01 | Inst Information Industry | 電器使用時間之估算方法、系統與電腦程式產品 |
| US9233788B2 (en) | 2010-01-22 | 2016-01-12 | Bayer Healthcare Llc | Biosensor desiccant system having enhanced measurement performance |
| CA2692097A1 (en) | 2010-02-04 | 2011-08-04 | Ignis Innovation Inc. | Extracting correlation curves for light emitting device |
| BR112012023984A2 (pt) * | 2010-03-22 | 2016-08-02 | Bayer Healthcare Llc | compensação residual para um biossensor |
| JP5856155B2 (ja) | 2010-06-07 | 2016-02-09 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ | バイオセンサのための充填不足管理システム |
| WO2011156152A1 (en) * | 2010-06-07 | 2011-12-15 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
| EP2491859A1 (en) * | 2011-02-23 | 2012-08-29 | F. Hoffmann-La Roche AG | Method and system for determining blood glucose characteristics from a discontinuous mode of measurement and computer program product |
| TWI565943B (zh) | 2011-07-22 | 2017-01-11 | 拜耳保健公司 | 具有增進測量性能之生物感測器乾燥劑系統 |
| ES2757909T3 (es) | 2011-09-21 | 2020-04-30 | Ascensia Diabetes Care Holdings Ag | Analisis de compensación que incluye señales segmentadas |
| US9903830B2 (en) * | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| JP6128772B2 (ja) * | 2012-07-27 | 2017-05-17 | 株式会社アプリクス | 化学分析装置の校正方法及び化学分析装置 |
| EP2936124B1 (en) | 2012-12-20 | 2017-03-15 | Roche Diabetes Care GmbH | Methods for evaluating medical measurement curves |
| EP2972397B1 (en) | 2013-03-14 | 2021-10-13 | Ascensia Diabetes Care Holdings AG | System error compensation of analyte concentration determinations |
| ES2812806T3 (es) * | 2013-03-14 | 2021-03-18 | Ascensia Diabetes Care Holdings Ag | Calibración normalizada de determinaciones de la concentración de analito |
| ES2715407T3 (es) * | 2013-03-14 | 2019-06-04 | Ascensia Diabetes Care Holdings Ag | Aproximación progresiva de la concentración de un analito de muestra |
| CA2900607C (en) * | 2013-03-15 | 2017-10-03 | F. Hoffmann-La Roche Ag | Descriptor-based methods of electrochemically measuring an analyte as well as devices, apparatuses and systems incoporating the same |
| JP6356707B2 (ja) * | 2013-03-15 | 2018-07-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 電気化学的測定中に高抗酸化物質レベルを検出してそれから分析物濃度をフェイルセイフする方法並びにそれを組み込んだデバイス、装置、及びシステム |
| GB2512842A (en) * | 2013-04-08 | 2014-10-15 | Sphere Medical Ltd | Sensor calibration method and apparatus |
| FR3005505B1 (fr) * | 2013-05-13 | 2015-05-01 | Biomerieux Sa | Procede de mesure de la concentration plasmatique d'un analyte directement sur un echantillon de sang total |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| GB2531728A (en) * | 2014-10-27 | 2016-05-04 | Cilag Gmbh Int | Method for determining diffusion |
| CN104569407B (zh) * | 2014-12-25 | 2017-06-06 | 深圳市康博霖科技有限公司 | 一种真菌毒素检测数据库的构建方法、真菌毒素检测方法、试剂盒及装置 |
| CN107636452B (zh) * | 2015-05-15 | 2021-06-08 | 安晟信医疗科技控股公司 | 改进的生物传感器系统分析物测量 |
| CN105021805B (zh) * | 2015-08-21 | 2018-03-06 | 三诺生物传感股份有限公司 | 一种人体生理参数检测结果的校正方法 |
| CN109690304A (zh) | 2016-07-12 | 2019-04-26 | 安晟信医疗科技控股公司 | 通过使用来自两个电极的交替输出信号进行电化学分析的方法 |
| HUE052845T2 (hu) * | 2016-09-07 | 2021-05-28 | Hoffmann La Roche | Eljárások enzimalapú elektrokémiai érzékelõk tesztelésére |
| CN106596962B (zh) * | 2016-11-01 | 2018-07-03 | 武汉璟泓万方堂医药科技股份有限公司 | 一种基于血糖试纸测试值衰减的code定值修正方法 |
| JP6595122B2 (ja) | 2016-11-25 | 2019-10-23 | Ｐｈｃホールディングス株式会社 | 生体試料の成分を測定する方法 |
| CN110249219B (zh) | 2016-12-05 | 2022-08-23 | 安晟信医疗科技控股公司 | 风险因素监测 |
| TWI652480B (zh) * | 2017-12-28 | 2019-03-01 | 合世生醫科技股份有限公司 | 血液分析物量測方法及裝置 |
| US11382541B2 (en) * | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
| JP2022514833A (ja) * | 2018-12-19 | 2022-02-16 | ゲンティアン アクティーゼルスカブ | 全血試料中のヘマトクリット値の測定方法 |
| CN113853514B (zh) * | 2019-05-21 | 2025-11-04 | 安晟信医疗科技控股公司 | 用于分析物生物传感器中的热敏电阻感测的补偿系统及方法 |
| FR3111064B1 (fr) * | 2020-06-08 | 2022-09-09 | Panoramic Digital Health | procédé de traitement de mesures effectuées par un capteur porté par une personne |
| CN115698680A (zh) * | 2020-06-18 | 2023-02-03 | 挪威金田有限公司 | 确定全血样品血浆成分中分析物浓度的方法 |
| CN115667903B (zh) * | 2020-12-21 | 2025-05-09 | 富士设计科技有限公司 | 测量装置及测量方法 |
| CN115700377A (zh) * | 2021-07-14 | 2023-02-07 | 疆域康健创新医疗科技成都有限公司 | 医疗检测装置及检测方法 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3765841A (en) * | 1971-08-06 | 1973-10-16 | Beckman Instruments Inc | Method and apparatus for chemical analysis |
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| IT1238090B (it) * | 1989-10-25 | 1993-07-07 | Marelli Autronica | Sistema per il controllo del riscaldamento dell'abitacolo di un autoveicolo |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| JPH04309856A (ja) * | 1991-04-05 | 1992-11-02 | Toshiba Corp | 分析計 |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| AU722471B2 (en) * | 1995-10-17 | 2000-08-03 | Lifescan, Inc. | Blood glucose strip having reduced sensitivity to hematocrit |
| RU2089906C1 (ru) * | 1995-12-09 | 1997-09-10 | Панасенко Николай Геннадьевич | Способ исследования биологических жидкостей и устройство для его осуществления |
| US5723284A (en) | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| US5753429A (en) * | 1996-08-09 | 1998-05-19 | Lifescan, Inc. | Analyte concentration measurement using a hollow frustum |
| DK0958495T3 (da) | 1997-02-06 | 2003-03-10 | Therasense Inc | In vitro analysand sensor med lille volumen |
| US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| JP2002505008A (ja) | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | 分析物のｉｎ ｖｉｖｏ測定のためのセンサーをキャリブレートし、試験する方法と、このような方法に用いるためのデバイス |
| US7494816B2 (en) | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
| DE69840916D1 (de) | 1997-12-22 | 2009-07-30 | Roche Diagnostics Operations | Messgerät |
| ATE258028T1 (de) | 1998-05-13 | 2004-02-15 | Cygnus Therapeutic Systems | Signalverarbeitung zur messung von physiologischen analyten |
| RU2137126C1 (ru) * | 1998-05-13 | 1999-09-10 | Тверская государственная медицинская академия | Способ исследования биологических жидкостей и устройство для его осуществления |
| US6576117B1 (en) | 1998-05-20 | 2003-06-10 | Arkray | Method and apparatus for electrochemical measurement using statistical technique |
| US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| CA2385842C (en) | 1999-09-20 | 2008-12-09 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
| JP4050434B2 (ja) | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| EP1197749B1 (en) * | 2000-03-29 | 2016-07-20 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor |
| JP3972063B2 (ja) | 2001-01-17 | 2007-09-05 | アークレイ株式会社 | センサを用いる定量分析方法および定量分析装置 |
| WO2003044513A1 (en) * | 2001-11-20 | 2003-05-30 | Arkray, Inc. | Fail judging method and analyzer |
| AU2003234944A1 (en) | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| US7132041B2 (en) * | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| EP1467206A1 (en) * | 2003-04-08 | 2004-10-13 | Roche Diagnostics GmbH | Biosensor system |
| US7488601B2 (en) * | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| ES2709991T3 (es) | 2003-08-21 | 2019-04-22 | Agamatrix Inc | Método y aparato para el análisis de propiedades electroquímicas |
| US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| JP2005156316A (ja) * | 2003-11-25 | 2005-06-16 | Toshiba Corp | マイクロ波式濃度計 |
| CN1938590B (zh) | 2004-04-19 | 2010-05-05 | 松下电器产业株式会社 | 血液成分的测定方法、该方法中使用的生物传感器和测定装置 |
| RU2006144458A (ru) | 2004-05-14 | 2008-06-20 | БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) | Способы осуществления корректировки по гематокриту в анализах глюкозы и устройства для этого |
| US8211038B2 (en) * | 2004-09-17 | 2012-07-03 | Abbott Diabetes Care Inc. | Multiple-biosensor article |
| KR101365933B1 (ko) | 2004-10-12 | 2014-02-24 | 바이엘 헬스케어 엘엘씨 | 샘플 내 분석물의 농도를 측정하기 위한 전기화학 시스템 |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| JP4576624B2 (ja) * | 2005-03-02 | 2010-11-10 | 独立行政法人産業技術総合研究所 | 針一体型バイオセンサー |
| US7517439B2 (en) | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| EP1728468A1 (de) * | 2005-06-04 | 2006-12-06 | Roche Diagnostics GmbH | Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung |
| ES2717135T3 (es) * | 2005-07-20 | 2019-06-19 | Ascensia Diabetes Care Holdings Ag | Método para señalar al usuario para que añada una muestra adicional a una tira de prueba, método para medir la temperatura de una muestra y métodos para determinar la concentración de un analito basados en amperometría controlada |
| ES2558873T3 (es) | 2005-07-26 | 2016-02-09 | Bayer Healthcare Llc | Procedimiento y sistema de verificación de un biosensor electromecánico |
| KR101477815B1 (ko) | 2005-09-30 | 2015-01-02 | 바이엘 헬스케어 엘엘씨 | 게이트형 전압 전류 측정법 |
| CA3044828A1 (en) | 2006-02-27 | 2007-09-07 | Ascensia Diabetes Care Holdings Ag | Temperature adjusted analyte determination for biosensor systems |
| CN101055262A (zh) * | 2006-04-11 | 2007-10-17 | 禅谱科技股份有限公司 | 抛弃式电化学感测试片及其制造方法 |
| BRPI0711433A2 (pt) * | 2006-05-08 | 2011-11-16 | Bayer Healthcare Llc | sistema de detecção de saìda anormal para um biosensor |
| RU2342071C2 (ru) * | 2007-01-29 | 2008-12-27 | Игорь Алексеевич Новиков | Способ определения концентрации глюкозы в крови человека |
| US20080248581A1 (en) | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| US8551320B2 (en) * | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| CN102984999B (zh) * | 2010-07-19 | 2016-05-04 | 西拉格国际有限责任公司 | 用于测量样品中分析物的系统和方法 |
-
2008
- 2008-12-06 JP JP2010538067A patent/JP5812603B2/ja active Active
- 2008-12-06 WO PCT/US2008/085768 patent/WO2009108239A2/en not_active Ceased
- 2008-12-06 MX MX2010006392A patent/MX2010006392A/es active IP Right Grant
- 2008-12-06 BR BRPI0820670-8A patent/BRPI0820670A2/pt not_active IP Right Cessation
- 2008-12-06 CN CN201310625384.1A patent/CN103760356B/zh active Active
- 2008-12-06 CA CA2708038A patent/CA2708038A1/en not_active Abandoned
- 2008-12-06 RU RU2010128653/15A patent/RU2546012C2/ru not_active Application Discontinuation
- 2008-12-06 EP EP18189664.8A patent/EP3438661B1/en active Active
- 2008-12-06 CN CN2008801200351A patent/CN101999073B/zh active Active
- 2008-12-06 RU RU2015105353A patent/RU2706691C2/ru active
- 2008-12-06 EP EP08872877.9A patent/EP2223104B1/en active Active
- 2008-12-08 US US12/329,698 patent/US10739350B2/en active Active
- 2008-12-09 TW TW103142985A patent/TWI534429B/zh not_active IP Right Cessation
- 2008-12-09 TW TW97147779A patent/TWI468689B/zh not_active IP Right Cessation
-
2015
- 2015-09-15 JP JP2015181883A patent/JP6448504B2/ja active Active
-
2018
- 2018-06-05 JP JP2018107600A patent/JP2018173415A/ja active Pending
-
2020
- 2020-07-21 US US16/934,963 patent/US20200348306A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN103760356A (zh) | 2014-04-30 |
| US10739350B2 (en) | 2020-08-11 |
| JP6448504B2 (ja) | 2019-01-09 |
| RU2015105353A3 (enExample) | 2018-10-11 |
| MX2010006392A (es) | 2010-07-02 |
| CN103760356B (zh) | 2019-06-28 |
| CN101999073B (zh) | 2013-12-18 |
| CN101999073A (zh) | 2011-03-30 |
| WO2009108239A3 (en) | 2009-11-26 |
| JP5812603B2 (ja) | 2015-11-17 |
| RU2546012C2 (ru) | 2015-04-10 |
| EP2223104B1 (en) | 2018-08-29 |
| JP2016028246A (ja) | 2016-02-25 |
| TW200933147A (en) | 2009-08-01 |
| RU2015105353A (ru) | 2015-06-20 |
| TWI534429B (zh) | 2016-05-21 |
| BRPI0820670A2 (pt) | 2015-06-16 |
| JP2018173415A (ja) | 2018-11-08 |
| TW201510527A (zh) | 2015-03-16 |
| US20090177406A1 (en) | 2009-07-09 |
| RU2706691C2 (ru) | 2019-11-20 |
| EP2223104A2 (en) | 2010-09-01 |
| TWI468689B (zh) | 2015-01-11 |
| WO2009108239A2 (en) | 2009-09-03 |
| US20200348306A1 (en) | 2020-11-05 |
| HK1154656A1 (en) | 2012-04-27 |
| RU2010128653A (ru) | 2012-01-20 |
| EP3438661B1 (en) | 2022-08-03 |
| EP3438661A1 (en) | 2019-02-06 |
| JP2011506966A (ja) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200348306A1 (en) | Slope-Based Compensation | |
| US20200271615A1 (en) | Biosensor Systems for Determining Analyte Concentration Based On Complex Index Functions | |
| US9995702B2 (en) | Slope-base compensation including secondary output signals | |
| JP2011506966A5 (enExample) | ||
| CA3044828A1 (en) | Temperature adjusted analyte determination for biosensor systems | |
| JP2012511160A5 (enExample) | ||
| HK1154656B (en) | Slope-based compensation | |
| HK1194136A (en) | Slope-based compensation | |
| HK1194136B (zh) | 斜率式补偿 | |
| HK1179346B (en) | Biosensor system with signal adjustment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20131205 |
|
| FZDE | Discontinued |
Effective date: 20210831 |
|
| FZDE | Discontinued |
Effective date: 20210831 |